CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats

Antiviral Research

Volumn 38, Issue 1, 1998, Pages 31-42

  Wyde, Philip R ^a   Moore Poveda, Donna K ^a   O'Hara, Bryan ^b   Ding, Wei Dong ^b   Mitsner, Boris ^b   Gilbert, Brian E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

Antiviral; Bronchiolitis; Cotton rats; Pneumonia; Prophylaxis; RSV

Indexed keywords

ANTIVIRUS AGENT; CL 387626; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TISSUE CULTURE CELL; TOXICITY; VERO CELL;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MOLECULAR STRUCTURE; RATS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SIGMODONTINAE; TRIAZINES; TUMOR CELLS, CULTURED; VERO CELLS;

ANIMALIA; GOSSYPIUM HIRSUTUM; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SIGMODON; SYNCYTIAL VIRUS;

EID: 0032054629     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(98)00002-3     Document Type: Article

References (15)

1. Bradley, J.S., Conner, J.D., Campogiannis, L.M., 1990. Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infection. Antimicrob.Agents Chemother. 34, 68-70.
2. Chanock, R.M., McIntosh, K., 1990. Parainfluenza viruses. In: Fields, B.N. (Ed.), Virology. Raven Press, New York, pp. 963-988.
3. Committee on Infectious Diseases, 1993. Use of ribavirin in the treatment of respiratory syncytial virus in infection. Pediatrics 92, 501-504.
4. Dowell, S.F., Anderson, L.J., Gary, H.E. Jr., Erdman, D.D., Plouffe, J.F., File, T.M. Jr., Marston, B.J., Breiman, R.F., 1996. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J. Infect. Dis. 174, 456-462.
5. Glezen, W.P., Loda, F.A., Denny, F.W., 1982. The parainfluenza viruses. In: Evans, A. S. (Ed.), Viral Infections of Humans: Epidemiology and Control. Plenum Press, New York, pp. 337-349.
6. Johnson, S., Oliver, C., Prince, G.A., Hemming, V.G., Pfarr, D.S., Wang, S.C., Dormitzer, M., O'Grady, J., Koenig, S., Tamura, J.K., Woods, R., Bansal, G., Couchenour, D., Tsao, E., Hall, W.C., Young, J.F., 1997. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J. Infect. Dis. 176, 1215-1224.
7. La Via, W.V., Marks, M.I., Stutman, H.R., 1992. Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment and prevention. J. Pediatr. 121, 503-510.
8. Parrott, R.H., Kim, H.W., Arrobio, J.O., Hodes, D.S., Murphy, B.R., Brandt, C.D., Camargo, E., Chanock, R.M., 1973. Epidemiology of respiratory syncytial virus infection in Washington, DC. Am. J. Epidemiol. 98, 289-300.
9. Piedra, P.A., Wyde, P.R., Castleman, W.L., Ambrose, M.W., Jewell, A.M., Speilman, D.J., Hildreth, S.W., 1993. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine 11, 1415-1423.
10. Prince, G.A., Porter, D.D., 1996. Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid. J. Infect. Dis. 173, 598-608.
11. Rhodes, A.J., Van Rooyen, C.E., 1953. Textbook of Virology, 2nd ed. Williams and Wilkins, Baltimore, MD, pp. 66-69.
12. Wilson, S.Z., Knight, V., Wyde, P.R., Drake, S., Couch, R.B., 1980. Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob. Agents Chemother. 17, 642-648.
13. Wyde, P.R., Wilson, S.Z., Kramer, M.J., Sun, C.-S., Knight, V., 1984. Duration of effect of interferon aerosol prophylaxis of vesicular stomatitis virus infection in mice. Antimicrob. Agents Chemother. 27, 60-64.
14. Wyde, P.R., Meyerson, L.R., Gilbert, B.E., 1993. An in vitro evaluation of the antiviral activity of SP-303, an euphorbiaceae shrub extract, against a panel of respiratory virus. Drug Dev. Res. 28, 467-472.
15. Wyde, P.R., Moore, O.K., Hepburn, T., Silverman, C.L., Porter, T.G., Gross, M., Taylor, G., Demuth, S.G., Dillon, S.B., 1995. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats. Pediatr. Res. 38, 543-550.